Bertrand Damour has been pro- moted from CFO to CEO of Geneva, Switzerland-based GeneProt. He replaces former CEO Cédric Loiret-Bernal, who left left the company last April.
Confirmant of Abingdon, UK, has elected new members to its scientific advisory board: Graham Cameron, associate director of the European Bioinformatics Institute in Cambridge; Duncan Campbell, director of the MRC HGMP Resource Center in Cambridge; and Michael Liebman, director for computational biology and biomedical informatics at the Abramson Cancer Center of the University of Pennsylvania.
Darryl Pappin has become director of chemistry, discovery proteomics, and the small molecule research center at Applied Biosystems in Framingham, Mass. He joined the company last fall from Imperial College London, where he was professor of proteomics. Previously, he was a senior scientist at Imperial Cancer Research Fund in London.
John Kozarich, CEO and CSO of ActivX Biosciences, based in La Jolla, Calif., has been elected to the board of directors of San Diego-based Ligand Pharmaceuticals.
Definiens of Munich has added to its management team: Jens Finnern, director for business development, joins the company from the German Cancer Research Institute, where he was executive managing director. Ralph Humberg, director for channel sales, was previously ADVA Optical Networking’s director for Asia-Pacific business. Manfred Voglmaier, director for sales, joins Definiens from NuGenesis Technologies, where he was managing director. In addition, J rgen Klenk has been promoted from director of R&D to vice president and chief technology officer.